Also called: PSP · Richardson-Steele-Olszewski syndrome · Steele-Richardson-Olszewski syndrome
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is a rare brain disease. It happens because of damage to nerve cells in the brain. PSP affects your movement, including control of your walking and balance. It also affects your thinking and eye movement.
PSP is progressive, which means that it gets worse over time.
The cause of PSP is unknown. In rare cases, the cause is a mutation in a certain gene.
One sign of PSP is abnormal clumps of tau in nerve cells in the brain. Tau is a protein in your nervous system, including in nerve cells. Some other diseases also cause a buildup of tau in the brain, including Alzheimer's disease.
PSP usually affects people over 60, but in some cases it can start earlier. It is more common in men.
Symptoms are very different in each person, but they may include:
- A loss of balance while walking. This is often the first symptom.
- Speech problems
- Trouble swallowing
- A blurring of vision and problems controlling eye movement
- Changes in mood and behavior, including depression and apathy (a loss of interest and enthusiasm)
- Mild dementia
There is no specific test for PSP. It can be difficult to diagnose, because the symptoms are similar to other diseases such as Parkinson's disease and Alzheimer's disease.
To make a diagnosis, your health care provider will take your medical history and do physical and neurological exams. You may have an MRI or other imaging tests.
There is currently no effective treatment for PSP. Medicines may reduce some symptoms. Some non-drug treatments, such as walking aids and special glasses, may also help. People with severe swallowing problems may need gastrostomy. This is a surgery to insert a feeding tube into the stomach.
PSP gets worse over time. Many people become severely disabled within three to five years after getting it. PSP isn't life-threatening on its own. It can still be dangerous because it increases your risk of pneumonia, choking from swallowing problems, and injuries from falling. But with good attention to medical and nutritional needs, many people with PSP can live 10 or more years after the first symptoms of the disease.
It sits within Brain and Nerves.
The lead U.S. institute for this subject is the National Institute of Neurological Disorders and Stroke.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Progressive Supranuclear Palsy
168 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- The Progressive Supranuclear Palsy Clinical Trial PlatformAdam Boxer
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)Mayo Clinic
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear PalsyNovartis Pharmaceuticals
- Remote Monitoring in Progressive Supranuclear Palsy (PSP)Massachusetts General Hospital
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaNational Institute of Neurological Disorders and Stroke (NINDS)
- Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)University of Michigan
Research already completed
- First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the BrainInvicro
- Trial of Parkinson's And Zoledronic AcidCalifornia Pacific Medical Center Research Institute
- Research of Biomarkers in Parkinson DiseaseInstitut National de la Santé Et de la Recherche Médicale, France
- AMX0035 and Progressive Supranuclear PalsyAmylyx Pharmaceuticals Inc.
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Learn More
- Progressive supranuclear palsyMedical Encyclopedia
- Progressive Supranuclear PalsyMayo Foundation for Medical Education and Research
- Progressive Supranuclear Palsy (PSP)National Institute of Neurological Disorders and Stroke
- Progressive Supranuclear Palsy (PSP): Frequently Asked QuestionsFoundation for PSP/CBD and Related Brain Diseases
Genetics
- Progressive supranuclear palsy: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: Supranuclear Palsy, ProgressiveNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Supranuclear Palsy, Progressive. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Progressive Supranuclear Palsy, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.